These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34262673)

  • 21. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
    Mancuso P; Gidaro A; Gregato G; Raveane A; Cremonesi P; Quarna J; Caccia S; Gusso L; Rusconi S; Giacomelli A; Cogliati C; Bertolini F
    J Thromb Haemost; 2020 Oct; 18(10):2744-2750. PubMed ID: 32762140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.
    Hisada Y; Sachetto ATA; Mackman N
    Immunol Rev; 2022 Nov; 312(1):61-75. PubMed ID: 35708588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral Bad News Sent by EVAIL.
    Clauss M; Chelvanambi S; Cook C; ElMergawy R; Dhillon N
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue Factor and COVID-19: An Update.
    Sachetto ATA; Mackman N
    Curr Drug Targets; 2022 Nov; 23(17):1573-1577. PubMed ID: 36165519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19.
    Cloer C; Roudsari L; Rochelle L; Petrie T; Welch M; Charest J; Tan K; Fugang L; Petersen T; Ilagan R; Hogan S
    PLoS One; 2021; 16(11):e0259732. PubMed ID: 34780505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
    J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites.
    Alzahrani FA; Shait Mohammed MR; Alkarim S; Azhar EI; El-Magd MA; Hawsawi Y; Abdulaal WH; Yusuf A; Alhatmi A; Albiheyri R; Fakhurji B; Kurdi B; Madani TA; Alguridi H; Alosaimi RS; Khan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burn Injury-Induced Extracellular Vesicle Production and Characteristics.
    Yang X; Chatterjee V; Zheng E; Reynolds A; Ma Y; Villalba N; Tran T; Jung M; Smith DJ; Wu MH; Yuan SY
    Shock; 2022 Jun; 57(6):228-242. PubMed ID: 35613455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
    Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
    Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity.
    Aharon A; Dangot A; Kinaani F; Zavaro M; Bannon L; Bar-Lev T; Keren-Politansky A; Avivi I; Jacob G
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection.
    Balbi C; Burrello J; Bolis S; Lazzarini E; Biemmi V; Pianezzi E; Burrello A; Caporali E; Grazioli LG; Martinetti G; Fusi-Schmidhauser T; Vassalli G; Melli G; Barile L
    EBioMedicine; 2021 May; 67():103369. PubMed ID: 33971404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation.
    Liao TL; Liu HJ; Chen DY; Tang KT; Chen YM; Liu PY
    Cell Commun Signal; 2023 Oct; 21(1):304. PubMed ID: 37904132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
    Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X
    J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients.
    Tertel T; Tomić S; Đokić J; Radojević D; Stevanović D; Ilić N; Giebel B; Kosanović M
    J Extracell Vesicles; 2022 Aug; 11(8):e12257. PubMed ID: 35979935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications.
    Ma Z; Yang KY; Huang Y; Lui KO
    J Mol Cell Cardiol; 2022 Mar; 164():69-82. PubMed ID: 34838588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity.
    Townsend L; Dowds J; O'Brien K; Sheill G; Dyer AH; O'Kelly B; Hynes JP; Mooney A; Dunne J; Ni Cheallaigh C; O'Farrelly C; Bourke NM; Conlon N; Martin-Loeches I; Bergin C; Nadarajan P; Bannan C
    Ann Am Thorac Soc; 2021 Jun; 18(6):997-1003. PubMed ID: 33413026
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.